Literature DB >> 12452327

Dietary sodium restriction restores nocturnal reduction of blood pressure in patients with primary aldosteronism.

Hiroshi Takakuwa1, Kazuaki Shimizu, Yoshiaki Izumiya, Tamayo Kato, Izaya Nakaya, Hitoshi Yokoyama, Ken-ichi Kobayashi, Takuyuki Ise.   

Abstract

The purpose of this study was to elucidate the effects of dietary sodium restriction on diurnal blood pressure (BP) variation in primary aldosteronism. We studied the diurnal variation in the systemic hemodynamic indices and in baroreflex sensitivity (BRS). In 13 subjects with aldosterone-producing adenomas (2 males; mean age, 39+/-2 years), intra-arterial pressure was monitored telemetrically on a normal salt diet (NaCl 10-12 g/day). Non-dippers were defined as those with a nocturnal reduction in systolic BP (SBP) of less than 10% of daytime SBP. Ten subjects showed a non-dipper pattern. Six of these "non-dippers" underwent repetitive hemodynamic studies on the last day of a 1-week low salt diet regimen (NaCl 2-4 g/day). Stroke volume was determined using Wesseling's pulse contour method, calibrated with indocyanine green dilution. BRS was calculated every 30 min as delta pulse interval/delta SBP on spontaneous variations. Nocturnal reduction of SBP was 4.1% on the normal salt diet. With sodium restriction, urinary sodium excretion decreased from 187+/-8 to 46+/-8 mmol/day, and body weight decreased from 57.9+/-2.1 to 56.6+/-1.9 kg. Night-time BP significantly decreased with dietary modification from 154+/-7/88+/-4 to 140+/-6/78+/-4 mmHg, whereas daytime BP was unaltered. With sodium restriction, cardiac index and stroke index decreased throughout the day. No significant difference was seen in either daytime or nighttime BRS between the two diets. We conclude that the non-dipper pattern is common in patients with an aldosterone-producing adenoma on a normal salt intake, and under such conditions, volume expansion appears to play a major role in the impairment of nocturnal BP reduction.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12452327     DOI: 10.1291/hypres.25.737

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  12 in total

Review 1.  The Expanding Spectrum of Primary Aldosteronism: Implications for Diagnosis, Pathogenesis, and Treatment.

Authors:  Anand Vaidya; Paolo Mulatero; Rene Baudrand; Gail K Adler
Journal:  Endocr Rev       Date:  2018-12-01       Impact factor: 19.871

Review 2.  The circadian clock in the kidney.

Authors:  Lisa R Stow; Michelle L Gumz
Journal:  J Am Soc Nephrol       Date:  2011-03-24       Impact factor: 10.121

3.  Primary aldosteronism can alter peripheral levels of transforming growth factor beta and tumor necrosis factor alpha.

Authors:  C A Carvajal; A A Herrada; C R Castillo; F J Contreras; C B Stehr; L M Mosso; A M Kalergis; C E Fardella
Journal:  J Endocrinol Invest       Date:  2009-10       Impact factor: 4.256

4.  The value of losartan suppression test in the confirmatory diagnosis of primary aldosteronism in patients over 50 years old.

Authors:  Chin-Chi Kuo; Poojitha Balakrishnan; Yenh-Chen Hsein; Vin-Cent Wu; Shih-Chieh Jeff Chueh; Yung-Ming Chen; Kwan-Dun Wu; Ming-Jiuh Wang
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2014-07-16       Impact factor: 1.636

5.  Diurnal blood pressure pattern in patients with primary aldosteronism.

Authors:  S Zacharieva; M Orbetzova; A Elenkova; A Stoynev; M Yaneva; R Schigarminova; K Kalinov; E Nachev
Journal:  J Endocrinol Invest       Date:  2006-01       Impact factor: 4.256

6.  The circadian clock protein Period 1 regulates expression of the renal epithelial sodium channel in mice.

Authors:  Michelle L Gumz; Lisa R Stow; I Jeanette Lynch; Megan M Greenlee; Alicia Rudin; Brian D Cain; David R Weaver; Charles S Wingo
Journal:  J Clin Invest       Date:  2009-07-01       Impact factor: 14.808

Review 7.  Circadian clock-mediated regulation of blood pressure.

Authors:  Lauren G Douma; Michelle L Gumz
Journal:  Free Radic Biol Med       Date:  2017-12-02       Impact factor: 7.376

8.  The association of nocturnal hypertension and nondipping blood pressure with treatment-resistant hypertension: The Jackson Heart Study.

Authors:  Marguerite R Irvin; John N Booth; Mario Sims; Adam P Bress; Marwah Abdalla; Daichi Shimbo; David A Calhoun; Paul Muntner
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-02-13       Impact factor: 3.738

Review 9.  Therapeutic Outcomes with Surgical and Medical Management of Primary Aldosteronism.

Authors:  Heather Wachtel; Douglas L Fraker
Journal:  Curr Cardiol Rep       Date:  2021-06-03       Impact factor: 3.955

10.  Using Predicted Atherosclerotic Cardiovascular Disease Risk for Discrimination of Awake or Nocturnal Hypertension.

Authors:  Swati Sakhuja; John N Booth; David E Anstey; Byron C Jaeger; Cora E Lewis; Donald M Lloyd-Jones; Joseph E Schwartz; Daichi Shimbo; James M Shikany; Mario Sims; Paul Muntner
Journal:  Am J Hypertens       Date:  2020-11-03       Impact factor: 3.080

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.